Zycov D

Zydus Cadila applies for emergency use authorisation for COVID-19 vaccine ZyCoV-D with DCGI

ZyCoV-D, a Plasmid DNA vaccine against COVID-19, will help not only adults but also adolescents in the 12 to 18 years age group, Zydus Cadila said

India okays Moderna vaccine for emergency use: How does it work and how effective is it?

Moderna vaccine: The Moderna jab was the second vaccine to get an emergency nod in the US after the Pfizer vaccine, another mRNA shot

Race for COVID-19 vaccine: Covaxin and ZyCoV-D begin human trials in India, Moderna publishes preliminary data from phase 1

While Covaxin is an inactivated whole-virion vaccine, ZyCoV-D is a DNA-plasmid based vaccine.

Zydus Cadila begins human trials of COVID-19 vaccine candidate ZyCoV-D in 1,000 volunteers

Zydus is only the second Indian pharma firm to get DCGI's nod for human trials of its vaccine candidate.

Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist

Aiming to launch a COVID-19 vaccine by 15 August, ICMR had written to select medical institutions to expedite clinical trials for the candidate COVAXIN